New hope for advanced cancer: DR30206 drug trial launches
Disease control
Recruiting now
This early-stage study tests a new drug, DR30206, in 216 adults with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants will receive t…
Phase: PHASE1 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC